Brilinta has been named in several suits claiming that the blood-thinning medication, Brilinta, allegedly increases the risk of serious injuries, including bleeding, stroke and heart attack. We are currently working with experienced Brilinta lawyers around the country, who can file a Brilinta lawsuit on your behalf and there is no fee until you receive a settlement or award. Contact us for a free (no obligation) case evaluation online or toll free.

man having a heart attack from the blood thinner Brilinta

Have You Experienced Uncontrollable Bleeding While Taking Brilinta?
Read Below On Why You May Have a Claim.

What is Brilinta?

Brilinta medicationBrilinta is a blood-thinning drug that is used to prevent dangerous blood clots from forming over the arteries in the heart. Brilinta is also used to prevent heart attacks and strokes for those who have recently had severe chest pain or recurring heart attacks. Brilinta is made by AstraZeneca, and was approved by the FDA in July 2011.

What Is the Problem With Brilinta?

blood-thinning drug brilintaThe problem with Brilinta is, either unexpectedly or as a result of an injury, users of Brilinta may bleed uncontrollably because Brilinta lacks a reversal agent, which would help stop the uncontrollable bleeding. Because of the missing antidote to stop the bleeding, this can also affect patients who suddenly need surgery, as their blood will be much thinner than normal.

Are There Brilinta Lawsuits or Settlements?

brilinta lawsuitsFebruary, 2014: A medical professor at Johns Hopkins University filed a lawsuit against AstraZeneca in the U.S. District of Columbia, claiming that the Brilinta manufacturer allegedly manipulated the results of the PLATO study, which led to fake results.

What Are the Common Brilinta Side Effects?

Brilinta side effects

  • Chest pain
  • Sudden numbness or weakness
  • Cardiovascular events
  • Confusion
  • Pale skin
  • Easy bruising
  • Bleeding
  • Vision problems
  • Heart attack
  • Stroke
  • Death

What is the FDA Doing?

fda meeting on Brilinta

August, 2013: Medical assessors for the FDA published a list of irregularities found in the PLATO clinical trial for Brilinta, including AstraZeneca’s failure to report serious adverse events in Brilinta users, with speculation that there was possible manipulation of the results.

July, 2016: The information on the box of Brilinta carries a “Black Box” warning about the risk of severe, sometimes fatal bleeding. It also warns that Brilinta becomes less effective when patients take more than 100-mg of aspirin. PDF.

What Are The Medical Studies Finding About Brilinta?

Brilinta medical studiesNew England Journal of Medicine (2009): The results of the PLATO clinical trial are published in the New England Journal of Medicine, which showed that there are substantially improved results among patients taking Brilinta, compared to patients taking Plavix, another blood-thinning drug.

International Journal of Cardiology (2013): Published a report demonstrating that the PLATO Brilinta clinical trial data presented to the FDA was manipulated prior to submission to increase the likelihood of marketing approval, and to make Brilinta seem safer than it could be with different test results.

European Society of Cardiology (2013): Published a report stating that many patients in their study were unable to tolerate Brilinta treatment when trying to correct their blood clots, leading to many patients discontinuing their use of Brilinta due to medical complications.

New England Journal of Medicine (2015): NEJM found that while Brilinta use may decrease the chances of a second heart attack in some patients while in use, the side effects of Brilinta may also increase the possibility of unsafe bleeding events.

American Heart Associated Scientific Sessions (2015): The study found that one-in-five patients taking Brilinta during clinical trials discontinued use of the of the drug because of the potential side effects, according to research offered during the Late Breaking Clinical Trial session at the 2015 American Heart Associated Scientific Sessions.

Reuters (2016): Clinical trial indicates that Brilinta isn’t any better than aspirin in helping patients with acute ischemic stroke or transient ischemic stroke, despite the company’s hopes of opening up a new market for the blood thinner.

Why Contact Us?

defective drug lawyerIf you or a loved one has suffered from uncontrollable bleeding, stroke or a heart attack while taking Brilinta, you may have a Brilinta lawsuit. You should talk to a Brilinta lawyer about your injuries and discuss your legal options. Our law firm is currently working with some of the more experienced attorneys in the country who handle these types of cases and charge no legal fees until you receive a settlement or award. Call our law firm toll-free at 1-800-992-6878 or fill out a contact form for a free legal consultation.